Zimbabwe has turned down a substantial American healthcare agreement valued at $367m (£272m) spanning five years due to Washington's insistence on confidential information.
The decision became public following a internal memorandum dated December was leaked, indicating that Head of State Emmerson Mnangagwa felt the agreement was "skewed".
A government spokesman later explained that the United States was requesting genetic material for scientific study and commercial purposes while was unwilling to share the resulting advantages from any future vaccines.
"We will now turn to the challenging and unfortunate task of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the United States had donated over $1.9bn in health funding to Zimbabwe during the past two decades.
A medical body in Zimbabwe has urged more talks to reach a agreement acceptable to all parties so the nation's critical HIV programme can proceed.
Wider Context
Zimbabwe's decision comes after a similar situation in Kenya, where a high court blocked a related deal with the US following legal challenges were filed about the security of Kenyans' medical information.
After resuming the presidency recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.
The agency had overseen aid for the US government, but Trump argued its spending was "wasteful" and his government was seeking direct bilateral deals to boost openness and responsibility.
According to statements, Sixteen nations in Africa have to date signed similar agreements, representing over $18.3bn in committed funds.
Details of the Declined Agreement
The money for Zimbabwe would have supported "tackling HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this collaboration would have delivered significant benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently on HIV treatment via US-supported initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to share its biological resources and data for a long time, without any corresponding assurance of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," his statement read.
"Effectively, our nation would supply the raw materials for medical research without any assurance that the resulting innovations would be available to our citizens if a future pandemic arise."
National Interest and Global Health
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were disrupting structures previously established through the international health agency.
The spokesperson gave as an example its Pandemic Benefit-Sharing framework created to manage future pandemics.
"This framework is designed to guarantee that when a country contributes its samples, the benefits – such as medicines and cures – are distributed fairly, not monopolised exclusively by those with the funds to create them."
Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," he added.
"We encourage further discussions with our American counterparts on how subsequent collaboration might be designed in a way that respects the independence and dignity of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it recognised the government's concerns, but recommended that talks should continue given that much of the nation's HIV programmes depended on foreign aid.
"Where specific concerns arise, such as those involving data governance or implementation frameworks, these can frequently be addressed through technical clarification and negotiated safeguards," it commented.
The situation underscores the complex challenges between receiving vital foreign assistance and protecting a country's data in an increasingly interconnected world.